507 related articles for article (PubMed ID: 32795544)
1. Urinary cannabinoid mass spectrometry profiles differentiate dronabinol from cannabis use.
Koch CD; Xu L; Curtis SA; Roberts JD; Bunch DR; El-Khoury JM
Clin Chim Acta; 2020 Nov; 510():515-521. PubMed ID: 32795544
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous quantification of THC-COOH, OH-THC, and further cannabinoids in human hair by gas chromatography-tandem mass spectrometry with electron ionization applying automated sample preparation.
Kieliba T; Lerch O; Andresen-Streichert H; Rothschild MA; Beike J
Drug Test Anal; 2019 Feb; 11(2):267-278. PubMed ID: 30144294
[TBL] [Abstract][Full Text] [Related]
3. Validation of a liquid chromatography tandem mass spectrometry (LC-MS/MS) method to detect cannabinoids in whole blood and breath.
Hubbard JA; Smith BE; Sobolesky PM; Kim S; Hoffman MA; Stone J; Huestis MA; Grelotti DJ; Grant I; Marcotte TD; Fitzgerald RL
Clin Chem Lab Med; 2020 Apr; 58(5):673-681. PubMed ID: 31527291
[TBL] [Abstract][Full Text] [Related]
4. 11-Nor-9-Carboxy-Δ8-Tetrahydrocannabinol, 7-Carboxy Cannabidiol, and 11-Nor-9-Carboxy-Δ9-Tetrahydrocannabinol in Urine by LC-MS/MS.
Hughs ML; McMillin GA
Methods Mol Biol; 2024; 2737():161-174. PubMed ID: 38036820
[TBL] [Abstract][Full Text] [Related]
5. Quantification of cannabinoids and their free and glucuronide metabolites in whole blood by disposable pipette extraction and liquid chromatography-tandem mass spectrometry.
Scheidweiler KB; Newmeyer MN; Barnes AJ; Huestis MA
J Chromatogr A; 2016 Jul; 1453():34-42. PubMed ID: 27236483
[TBL] [Abstract][Full Text] [Related]
6. Optimization of recombinant β-glucuronidase hydrolysis and quantification of eight urinary cannabinoids and metabolites by liquid chromatography tandem mass spectrometry.
Sempio C; Scheidweiler KB; Barnes AJ; Huestis MA
Drug Test Anal; 2018 Mar; 10(3):518-529. PubMed ID: 28815938
[TBL] [Abstract][Full Text] [Related]
7. Determination of cannabinoids in human cerumen samples by use of UPLC-MS/MS as a potential biomarker for drug use.
Christodoulou MC; Constantinou MS; Louppis AP; Christou A; Stavrou IJ; Kapnissi-Christodoulou CP
J Pharm Biomed Anal; 2023 Jul; 231():115412. PubMed ID: 37087774
[TBL] [Abstract][Full Text] [Related]
8. Quantification of six cannabinoids and metabolites in oral fluid by liquid chromatography-tandem mass spectrometry.
Desrosiers NA; Scheidweiler KB; Huestis MA
Drug Test Anal; 2015 Aug; 7(8):684-94. PubMed ID: 25428610
[TBL] [Abstract][Full Text] [Related]
9. Urinary Excretion Profile of Cannabinoid Analytes Following Acute Administration of Oral and Vaporized Cannabis in Infrequent Cannabis Users.
Sholler DJ; Zamarripa CA; Spindle TR; Martin EL; Kuntz D; Vandrey R; Grabenauer M
J Anal Toxicol; 2022 Oct; 46(8):882-890. PubMed ID: 35770374
[TBL] [Abstract][Full Text] [Related]
10. Identification and quantification of cannabinoids in postmortem fluids and tissues by liquid chromatography-tandem mass spectrometry.
Cliburn KD; Huestis MA; Wagner JR; Kemp PM
J Chromatogr A; 2021 Aug; 1652():462345. PubMed ID: 34198104
[TBL] [Abstract][Full Text] [Related]
11. Disposition of cannabichromene, cannabidiol, and Δ⁹-tetrahydrocannabinol and its metabolites in mouse brain following marijuana inhalation determined by high-performance liquid chromatography-tandem mass spectrometry.
Poklis JL; Thompson CC; Long KA; Lichtman AH; Poklis A
J Anal Toxicol; 2010 Oct; 34(8):516-20. PubMed ID: 21258613
[TBL] [Abstract][Full Text] [Related]
12. Determination of cannabinoids in hair: Indicators for illegal vs CBD-rich cannabis use.
Casati S; Angeli I; Bergamaschi RF; Ravelli A; Colombo G; Binelli G; Minoli M; Orioli M
Forensic Sci Int; 2022 Apr; 333():111237. PubMed ID: 35228140
[TBL] [Abstract][Full Text] [Related]
13. Detectability of cannabinoids in the serum samples of cannabis users: Indicators of recent cannabis use? A follow-up study.
Krämer M; Schäper M; Dücker K; Philipsen A; Losacker M; Dreimüller N; Engelmann J; Madea B; Hess C
Drug Test Anal; 2021 Sep; 13(9):1614-1626. PubMed ID: 34114750
[TBL] [Abstract][Full Text] [Related]
14. Detection of Cannabinoids by LC-MS-MS and ELISA in Breast Milk.
Sempio C; Wymore E; Palmer C; Bunik M; Henthorn TK; Christians U; Klawitter J
J Anal Toxicol; 2021 Aug; 45(7):686-692. PubMed ID: 33002141
[TBL] [Abstract][Full Text] [Related]
15. Proof of active cannabis use comparing 11-hydroxy-∆9-tetrahydrocannabinol with 11-nor-9-carboxy-tetrahydrocannabinol concentrations.
Franz T; Skopp G; Schwarz G; Musshoff F
Drug Test Anal; 2018 Oct; 10(10):1573-1578. PubMed ID: 29845743
[TBL] [Abstract][Full Text] [Related]
16. Detectability of various cannabinoids in plasma samples of cannabis users: Indicators of recent cannabis use?
Kraemer M; Madea B; Hess C
Drug Test Anal; 2019 Oct; 11(10):1498-1506. PubMed ID: 31407526
[TBL] [Abstract][Full Text] [Related]
17. Ultra-high-performance liquid chromatography-tandem mass spectrometry assay for quantifying THC, CBD and their metabolites in hair. Application to patients treated with medical cannabis.
Lo Faro AF; Venanzi B; Pilli G; Ripani U; Basile G; Pichini S; Busardò FP
J Pharm Biomed Anal; 2022 Aug; 217():114841. PubMed ID: 35636009
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous quantification of 11 cannabinoids and metabolites in human urine by liquid chromatography tandem mass spectrometry using WAX-S tips.
Andersson M; Scheidweiler KB; Sempio C; Barnes AJ; Huestis MA
Anal Bioanal Chem; 2016 Sep; 408(23):6461-71. PubMed ID: 27422645
[TBL] [Abstract][Full Text] [Related]
19. An assessment of qualitative and quantitative cannabinoids analysis in selected commercially available cannabis oils in Argentina.
Fernández N; Cappello MG; Quiroga PN
Forensic Sci Int; 2023 Aug; 349():111762. PubMed ID: 37392612
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid disposition in oral fluid after controlled smoked, vaporized, and oral cannabis administration.
Swortwood MJ; Newmeyer MN; Andersson M; Abulseoud OA; Scheidweiler KB; Huestis MA
Drug Test Anal; 2017 Jun; 9(6):905-915. PubMed ID: 27647820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]